DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Seck TL, Engel SS, Williams-Herman DE et al.
Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide.
Diabetes Res Clin Pract 2011;
93 (01) e15-e17
DOI: S0168-8227(11)00125-2 [pii];10.1016/j.diabres.2011.03.006 [doi].
http://www.ncbi.nlm.nih.gov/pubmed/21477878
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.